M.-K. Lau et al. / Journal of Organometallic Chemistry 689 (2004) 2401–2410
2403
2.4. [Ir(Buppy)2{N(Ph2PSe)2}] (9)
Recrystallization from CH2Cl2/Et2O/hexane afforded
orange (12, yield: 37%) or red crystals (13, yield: 43%).
12: Despite two attempts, we were not able to obtain
satisfactory elemental analyses. The compound has been
characterized by NMR spectroscopy and mass spec-
To a solution of 1 (50 mg, 0.039 mmol) in MeOH (20
ml) were added 2 equiv. of K[N(Ph2PSe)2] (0.077 mmol)
and the mixture was stirred at room temperature over-
night. The solvent was pumped off and the residue was
washed with Et2O. Recrystallization from CH2Cl2/hex-
ane gave the yellow crystalline product. Yield: 31 mg
(69%). Anal. Calc. for C54H52N3P2Se2Ir: C, 55.29; H,
1
trometry. H NMR (CDCl3): d 1.05 (s, 36H, t-Bu), 6.39
(d, 4H, J ¼ 1:8 Hz, H1), 6.99 (t, 8H, J ¼ 15 Hz, H2),
7.55–7.63 (m, 8H, H3 and H5), 7.73 (d, 4H, J ¼ 7:8 Hz,
H4), 9.01 (d, 4H, J ¼ 6 Hz, H7). MS (FAB): m=z 1539
(Mþ + 1).
1
4.64; N, 3.59. Found: C, 55.79; H, 4.75; N, 3.43%. H
NMR (CDCl3): d 0.95 (s, 18H, t-Bu), 5.96 (s, 2H, H1),
6.25 (t, 2H, J ¼ 6:7 Hz, H6), 6.83 (d, 2H, J ¼ 8 Hz, H2),
7.01–7.06 (m, 4H, phenyl protons), 7.35–7.43 (m, 12H,
H3 and phenyl protons), 7.64–8.01 (m, 6H, phenyl
protons), 8.01–8.08 (m, 4H, H4 and H5), 9.20 (d, 2H,
J ¼ 5:4 Hz, H7). 31P{1H} NMR (CDCl3): d 16.72 (s).
MS (FAB): m=z 1155 (Mþ).
13: Anal. Calc. for C60H64N4Se4WIr2: C, 41.69; H,
1
3.70; N, 3.24. Found: C, 41.56; H, 3.74; N, 3.09%. H
NMR (CDCl3): d 1.04 (s, 36H, t-Bu), 6.37 (d, 4H,
J ¼ 1:8 Hz, H1), 6.91–6.97 (m, 8H, H2 and H6), 7.53–
7.61 (m, 8H, H3 and H5), 7.72 (d, 4H, J ¼ 8:2 Hz, H4),
9.18 (d, 4H, J ¼ 6 Hz, H7), MS (FAB): m=z 1727 (Mþ).
2.7. [{Rh(Buppy)2}2(WQ4)] (Q ¼ S (14), Se (15))
2.5. [{M(Buppy)2}2(l-SCN)2] (M ¼ Ir (10), Rh (11))
These were prepared similarly as for 12 and 13, re-
spectively, using 2 instead of 1. Recrystallization from
CH2Cl2/hexane gave yellow (14, yield: 40%) or red (15,
yield: 45%) crystals.
To a solution of 1 (40 mg, 0.031 mmol) in MeOH (20
ml) was added Ag(OTf) (OTf ¼ triflate, 0.062 mmol) and
the mixture was stirred at room temperature for 1 h and
filtered. To the red filtrate was added KSCN (10 mg,
0.062 mmol) and the mixture was stirred for 3 h and
evaporated to dryness by a rotavapor. The residue was
washed with hexane and Et2O, and then extracted with
CH2Cl2. Recrystallization from CH2Cl2/hexane gave
yellow crystals. Yield: 15 mg (34%). Complex 11 was
prepared by a similar procedure, employing 2 (34 mg)
instead of 1. Yield: 19 mg (41%)
14: Anal. Calc. for C60H64N4S4WRh2 ꢁ H2O: C,
52.28; H, 4.79; N, 4.07. Found: C, 52.23; H, 4.64; N,
4.01%. 1H NMR (CDCl3): d 1.03 (s, 36H, t-Bu), 6.30 (s,
4H, H1), 6.85–7.05 (m, 8H, H2 and H6), 7.55 (d, 4H,
J ¼ 4 Hz, H3), 7.61–7.72 (m, 8H, H4 and H5), 8.92 (d,
4H, J ¼ 5:6 Hz, H7). MS (FAB): m=z 1359 (Mþ).
15: Anal. Calc. for C60H64N4Se4WRh2: C, 46.04; H,
1
4.21; N, 3.58. Found: C, 46.19; H, 4.15; N, 3.53%. H
NMR (CDCl3): d 1.04 (s, 36H, t-Bu), 6.31 (s, 4H, H1),
6.85–7.00 (m, 8H, H2 and H6), 7.53 (d, 4H, J ¼ 8:2 Hz,
H3), 7.60–7.72 (m, 8H, H4 and H5), 9.04 (d, 4H, J ¼ 5:8
Hz, H7). MS (FAB): m=z 1546 (Mþ).
1
3
10: Anal. Calc. for C62H64N6S2Ir2 ꢁ hexane: C, 56.09;
H, 5.05; N, 6.13. Found: C, 56.15; H, 5.01; N, 6.07%. 1H
NMR (CDCl3): d 1.01 (s, 18H, t-Bu), 1.05 (s, 18H, t-Bu),
6.12 (d, 4H, J ¼ 12:6 Hz, H1), 6.86 (dd, 2H, J1 ¼ 1:8 Hz,
J2 ¼ 7:8 Hz, H2), 6.78 (dd, 2H, J1 ¼ 1:8 Hz, J2 ¼ 7:8 Hz,
H20), 7.04 (t, 4H, J ¼ 7:2 Hz, H6), 7.32–7.42 (m, 4H,
H3), 7.71–7.82 (m, 8H, H4 and H5), 9.14 (d, 2H, J ¼ 5:4
Hz, H7), 9.88 (d, 2H, J ¼ 5:4 Hz, H70). IR (KBr, cmꢀ1):
2132 (s) [m(CBN)]. MS (FAB): m=z 1341 (Mþ).
2.8. [{Ir(Buppy)2}2{WO(l-S)2(l3-S)}] (16)
Complex 12 was dissolved in CH2Cl2 and was left to
stand in air at )10 °C for ca. 1 month. The yellow
crystals formed were collected and washed with hexanes.
Yield: 10%. Anal. Calc. for C60H64N4OS3-
WIr2 ꢁ CH2Cl2: C, 45.60; H, 4.14; N, 3.49. Found: C,
11: Anal. Calc. for C62H64N6S2Rh2: C, 64.02; H,
1
5.54; N, 7.22. Found: C, 63.87; H, 5.15; N, 7.12%. H
NMR (CDCl3): d 1.03 (s, 36H, t-Bu), 5.30 (s, 4H, H1),
6.26 (d, 4H, J ¼ 2 Hz, H2), 6.90 (t, 4H, J ¼ 7:8 Hz, H6),
7.48 (d, 4H, J ¼ 2 Hz, H3), 7.79–7.87 (m, 8H, H4 and
H5), 9.64 (d, 4H, J ¼ 5:4 Hz, H7). IR (KBr, cmꢀ1): 2129
(s) [m(CBN)]. MS (FAB): m=z 1163 (Mþ).
1
45.12; H, 4.11; N, 3.44%. H NMR (CDCl3): d 1.03 (s,
36H, t-Bu), 6.33 (s, 4H, H1), 6.81–7.04 (m, 8H, H2 and
H6), 7.53 (m, 4H, H5), 7.69 (d, 8H, H4), 9.07 (d, 4H, H7).
IR (KBr, cmꢀ1): 881 [m(W@O)]. MS (FAB): m=z 1522
(Mþ + 1).
2.6. [{Ir(Buppy)2}2(WQ4)] (Q ¼ S (12), Se (13))
2.9. X-ray crystallography
To a solution of 1 (0.036 mmol) in CH2Cl2 (20 ml)
was added 1 equiv. of [Et4N]2[WQ4] (0.036 mmol) and
the mixture was stirred at room temperature overnight.
The solvent was pumped off and the residue was washed
with hexane and Et2O and then extracted with CH2Cl2.
Crystallographic data and experimental details for
complexes 3, 4, 7 ꢁ 4CH2Cl2, and 8 are summarized in
Table 1 and those for 10 ꢁ C6H14, 11 ꢁ C6H14 ꢁ 2H2O,
15 ꢁ 2C6H14, and 16 ꢁ 4CH2Cl2 ꢁ 0.5H2O in Table 2. In-
tensity data of all complexes were collected on a Bruker